Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04934475
Title MInimal Residual Disease Adapted Strategy (MIDAS)
Acronym MIDAS
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Intergroupe Francophone du Myelome
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | BEL


No variant requirements are available.